Ellen Z. Baum
Johnson & Johnson Pharmaceutical Research & Development
L.L.C.
1000 Route 202
Raritan
USA
Name/email consistency: high
- A MurF inhibitor that disrupts cell wall biosynthesis in Escherichia coli. Baum, E.Z., Crespo-Carbone, S.M., Klinger, A., Foleno, B.D., Turchi, I., Macielag, M., Bush, K. Antimicrob. Agents Chemother. (2007)
- Utility of muropeptide ligase for identification of inhibitors of the cell wall biosynthesis enzyme MurF. Baum, E.Z., Crespo-Carbone, S.M., Abbanat, D., Foleno, B., Maden, A., Goldschmidt, R., Bush, K. Antimicrob. Agents Chemother. (2006)
- Identification of a dithiazoline inhibitor of Escherichia coli L,D-carboxypeptidase A. Baum, E.Z., Crespo-Carbone, S.M., Foleno, B., Peng, S., Hilliard, J.J., Abbanat, D., Goldschmidt, R., Bush, K. Antimicrob. Agents Chemother. (2005)
- A point mutation in influenza B neuraminidase confers resistance to peramivir and loss of slow binding. Baum, E.Z., Wagaman, P.C., Ly, L., Turchi, I., Le, J., Bucher, D., Bush, K. Antiviral Res. (2003)
